Panagi et al. have shown that combining tranilast and the cytotoxic chemotherapy drug Doxil significantly inhibits tumour progression and improves the efficacy of anti-PD-1 and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) in TNBC [146]. This evidence concerns the gene PDCD1 and neoplasm.